Financials

Discussions Technicals Forecast Seasonals

MLC fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Malin Corp. Plc. invests and supports innovative life sciences companies, which develops exceptional science and technology to deliver transformative outcomes for patients. Its priority assets includes Poseida, Immunocore, Kymab and Viamet. The company was founded on December 16, 2014 and is headquartered in Dublin, Ireland.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

MLC does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company